Английская Википедия:ABT-239

Материал из Онлайн справочника
Версия от 23:05, 26 декабря 2023; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{Drugbox | verifiedrevid = 477235076 | IUPAC_name = 4-(2-{2-[(2''R'')-2-Methylpyrrolidin-1-yl]ethyl}-<br>benzofuran-5-yl)benzonitrile | image = ABT-239.svg <!--Clinical data--> | tradename = <!--Identifiers--> | CAS_number = 460746-46-7 | CAS_supplemental = <BR>460746-51-4 (racemic)<BR>460749-29-5 (''S''-isomer) | UNII_Ref = {{fdacit...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

ABT-239 is an H3-receptor inverse agonist developed by Abbott. It has stimulant and nootropic effects, and has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia.[1][2][3][4] ABT-239 is more active at the human H3 receptor than comparable agents such as thioperamide, ciproxifan, and cipralisant. It was ultimately dropped from human trials after showing the dangerous cardiac side effect of QT prolongation,[5] but is still widely used in animal research into H3 antagonists / inverse agonists.

References

Шаблон:Reflist

External links

Шаблон:Histaminergics


Шаблон:Nervous-system-drug-stub